In this Podcast episode we return to the topic of stem cells. We discussed that autologous stem cells can be a powerful therapeutic tool for Parkinson’s disease in our interview with Professor Jeanne Loring. The challenge however is to manufacture those therapies at scale. Our guest on this episode is taking a major step in alleviating this hurdle. Meet Nabiha Saklayen, the co-founder and CEO of Cellino, a company that merges stem cell biology, laser physics and machine learning to make autologous stem cell therapies possible.

Together with Nabiha, we discussed:
◦ Her personal career story from physics to biotech
◦ Role of finding product/market fit early in a deep tech startup journey
◦ Importance of founding team for any startup
◦ Challenges in manufacturing of autologous cell therapeutics
◦ Cellino’s approach for automated selection and expansion of iPSCs
◦ Applications of stem cells in drug discovery
◦ The future of personalized stem cell therapies

Get in touch with Nabiha:
◦ LinkedIn: https://www.linkedin.com/in/nabihasaklayen/
◦ Twitter: @nabsicle
◦ Website (Cellino): https://www.cellinobio.com/

Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com